CD8A and neoplasm: An enrichment of GRB7+ and GNLY+ CD8+ T cells (cells/mm2 tumour area) was observed in tumours treated with PI3K/mTORi and PI3K/mTORi+PD1‐i compared to those treated with vehicle or PD‐1i alone (Figure S3F).